In 1970, some 7.5 billion U.S. dollars were spent on the Medicare program in the United States. Fifty plus years later, this figure stood at 1,122.1 billion U.S. dollars. This statistic depicts total Medicare spending from 1970 to 2024. Increasing Medicare coverage Medicare is the federal health insurance program in the U.S. for the elderly and those with disabilities. In the U.S., the share of the population with any type of health insurance has increased to over 90 percent in the past decade. As of 2019, approximately 18 percent of the U.S. population was covered by Medicare in particular. Increasing Medicare costs Medicare costs are forecasted to continue increasing over time, with outlays rising to a predicted 1.78 trillion U.S. dollars by 2031 as the population continues to age. Certain diseases of old age, such as Alzheimer’s disease, are increasing in prevalence in the U.S., which will reflect on healthcare costs for the elderly. In 2021, Alzheimer's disease was estimated to cost Medicare and Medicaid around 239 billion U.S. dollars in care costs; by 2050, this number is projected to climb to 798 billion dollars.

The Medicare Part B by Drug dataset presents information on spending for drugs administered in doctors’ offices and other outpatient settings by physicians and other healthcare providers to Medicare Part B enrollees.The dataset focuses on average spending per dosage unit and change in average spending per dosage unit over time. It also includes consumer-friendly descriptions of the drug uses, clinical indications, and manufacturer(s).Drug spending metrics for Part B drugs represent the full value of the product, including the Medicare payment and beneficiary liability. All Part B drug spending metrics are calculated at the HCPCS level.

Between 2019 and 2023, spending for Eliquis under Medicare increased by 31 percent annually on average per dosage unit. This statistic illustrates the average annual Medicare spending growth among select top-selling drugs in the United States, for the time range 2019-2023.

CMS has released several information products that provide spending information for prescription drugs in the Medicare and Medicaid programs. The CMS Drug Spending Dashboards are online interactive tools that provide spending information for certain prescription drugs in the Medicare and Medicaid programs. CMS selected drugs for inclusion in the dashboards based on three criteria 1) drugs with high spending on a per user basis (Medicare Program) and drugs with high spending on a per prescription fill basis (Medicaid Program) 2) drugs with high total program spending and 3) drugs with high costs increases in recent years. The dashboard tools display relevant spending, utilization, and trend data and also include consumer-friendly information on the drug product descriptions, manufacturer(s), and uses. In addition to the Dashboards, CMS has released Medicare spending and utilization data for all Part B and Part D drugs. These summary data files were the basis for the Medicare Drug Spending Dashboard and include annual data for the most recent five years.

In 2021, Medicare spent an average of more than 13,139 U.S. dollars per enrollee in New York, while the average for the United States was 11,080 U.S. dollars per enrollee. This statistic depicts the leading ten U.S. states based on Medicare spending per enrollee in 2021.

View yearly updates and historical trends for US Government Medicare Spending with Forecast. from United States. Source: Office of Management and Budget. …

View yearly updates and historical trends for US Government Mandatory Medicare Spending. from United States. Source: Office of Management and Budget. Trac…

This data package contains the information of Medicare and Medicaid healthcare spending and healthcare cost and percentages by state.

In 2020, traditional Medicare spending decreased in the months March to June 2020 for all age groups. This statistic illustrates traditional Medicare spending in 2020 in the United States, by month and age.

This dataset identifies health care spending at medical services such as hospitals, physicians, clinics, and nursing homes etc. as well as for medical products such as medicine, prescription glasses and hearing aids. This dataset pertains to personal health care spending in general. Other datasets in this series include Medicaid personal health care spending and Medicare personal health care spending.

Mandatory federal health spending in FY 2024. Notes: B is billion. ACA is Affordable Care Act. Medicare includes spending on Part A, Part B, and Part D spending, and excludes the value of offsetting receipts, which totaled $172.0 billion in FY 2024 ($5.4 billion for Part A, $141.8 billion for Part B, and $24.8 billion for Part D).

Notes: Amounts in billions. Amounts are for federal fiscal year 2024 and are adjusted to exclude effects of timing shifts. ¹Consists of mandatory Medicare spending minus income from premiums and other offsetting receipts. ²Includes spending on other mandatory outlays minus income from offsetting receipts. ACA is Affordable Care Act. CHIP is Children’s Health Insurance Program.

U.S. government data on Medicare drug spending related metrics such as total spending, total benefits, total claims, average spending per dosage, average spending per claim. Spans the time period 2018 - 2022.

Compared to the same months in 2019, traditional Medicare spending experienced a large drop between March and May of 2020, coinciding with the COVID-19 pandemic and resulting lockdowns. This statistic shows the total aggregate traditional Medicare spending in 2019 and 2020 in the United States, by month.

View yearly updates and historical trends for US Government Discretionary Medicare Spending. from United States. Source: Office of Management and Budget. …

Comprehensive analysis of Medicare physician spending across 10 years (2014-2023), covering provider payments, procedure costs, specialty breakdowns, and geographic trends derived from CMS public data.

Graph and download economic data for Personal current transfer receipts: Government social benefits to persons: Medicare (W824RC1) from Jul 1966 to Jan 2026 about social assistance, benefits, personal, government, and USA.

In 2023, Medicare spending on prescription drugs amounted to ***** billion U.S. dollars, the highest in the provided time interval. In 2006, the Medicare Prescription Payment Plan (MPPP) was introduced as part of the Medicare Modernization Act. This explains the steep rise in Medicare prescription payments from 2006. This statistic displays the total Medicare spending on prescription drugs in the United States from 1970 to 2023.

Graph and download economic data for Personal current transfer receipts: Government social benefits to persons: Medicare (W824RC1A027NBEA) from 1966 to 2025 about transfers, receipts, social assistance, benefits, personal, government, GDP, and USA.

Share of total drug costs paid by:. Notes: The manufacturer discount applies to brand-name drug costs only. For generic drug costs, plans paid 75% in the coverage gap phase in 2023 and 2024, and pay 75% in the initial coverage phase in 2025, and Medicare pays 40% in the catastrophic coverage phase in 2025.